51 related articles for article (PubMed ID: 10965960)
1. De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis.
Busebee B; Myhre L; Mara K; Aqel B; Taner T; Watt KD
Clin Transplant; 2024 Feb; 38(2):e15263. PubMed ID: 38375953
[TBL] [Abstract][Full Text] [Related]
2. De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK; Choi JY; Yoon SK
Ann Surg Treat Res; 2015 Sep; 89(3):145-50. PubMed ID: 26366384
[TBL] [Abstract][Full Text] [Related]
3. An overview of occult hepatitis B virus infection.
Said ZN
World J Gastroenterol; 2011 Apr; 17(15):1927-38. PubMed ID: 21528070
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?
Brock GN; Mostajabi F; Ferguson N; Carrubba CJ; Eng M; Buell JF; Marvin MR
Transpl Int; 2011 Jun; 24(6):570-81. PubMed ID: 21401727
[TBL] [Abstract][Full Text] [Related]
5. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
[TBL] [Abstract][Full Text] [Related]
6. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
Holt D; Thomas R; Van Thiel D; Brems JJ
Arch Surg; 2002 May; 137(5):572-5; discussion 575-6. PubMed ID: 11982471
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
[TBL] [Abstract][Full Text] [Related]
8. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
9. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
[TBL] [Abstract][Full Text] [Related]
10. Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors.
Dodson SF
Clin Transplant; 2000; 14 Suppl 2():20-4. PubMed ID: 10965960
[TBL] [Abstract][Full Text] [Related]
11. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Cholongitas E; Papatheodoridis GV; Burroughs AK
J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
[TBL] [Abstract][Full Text] [Related]
12. Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
Lin CC; Yong CC; Chen CL
World J Gastroenterol; 2015 Oct; 21(39):11112-7. PubMed ID: 26494965
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
